Back to company

SPECIFIC PHARMA A/S: Financial statements 2016

CVR: 33161395

SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 141,067,000 and a net result of DKK 20,193,000 compared with DKK 24,131,000 the year before. That is an increase of 6.9% compared with the year before. The profit margin was 14.3%. Equity amounted to DKK 63,523,000. The solvency ratio was 76.9%. The company had 8 employees in the financial year.

Revenue
141,067,000 kr.
Profit/Loss
20,193,000 kr.
Equity
63,523,000 kr.
Total Assets
82,561,000 kr.
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016141.1 mio.-20.2 mio.63.5 mio.8
2015132 mio.35.9 mio.24.1 mio.61.4 mio.4
2014137.8 mio.30.3 mio.18.7 mio.37.3 mio.-
201360.1 mio.16.8 mio.10.6 mio.18.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is SPECIFIC PHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About SPECIFIC PHARMA A/S

SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The company is owned by NOMECO A/S. The company has 24 employees. In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity amounted to DKK 98,645,000.